Evidence for a major gene elevating serum bilirubin concentration in Utah pedigrees

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 912-917

  Hunt, Steven C ^a,b   Wu, Lily L ^a   Hopkins, Paul N ^a   Williams, Roger R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Cardiovascular Genetics   (United States)

Author keywords

coronary heart disease; genetics; risk factor; segregation analysis

Indexed keywords

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CORONARY RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MAJOR GENE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SEGREGATION ANALYSIS; UNITED STATES;

EID: 0029818589     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.912     Document Type: Article

References (23)

1. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994;40:18-23.
2. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent CM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vase Biol. 1996;16:250-255.
3. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem. 1995;41:1504-1508.
4. Williams RR, Skolnick M, Carmelli D, Maness AT, Hunt SC, Hasstedt SJ, Reiber GE, Jones RK. Utah pedigree studies: design and preliminary data for premature male CHD deaths. In: Sing CF, Skolnick M, eds. The Genetic Analysis of Common Diseases. New York, NY: Alan R. Liss, Inc; 1979:711-729.
5. Williams RR, Hopkins PN, Hunt SC, Wu LL, Hasstedt SJ, Lalouel JM, Ash KO, Stults BM, Kuida H. Population-based frequency of dyslipidemia syndromes in coronary prone families in Utah. Arch Intern Med. 1990;150:582-588.
6. Williams RR, Hunt SC, Schumacher MC, Hopkins PN, Wu LL, Barlow GK, Stults BM, Wilson DE, Lalouel JM. Genes, hypertension and coronary heart disease: evidence for shared metabolic pathophysiology. In: Smith U, Bruun NE, Hedner T, Hokfelt B, eds. Hypertension: An Insulin-Resistant Disorder - Genetic Factors and Cellular Mechanisms. Amsterdam, the Netherlands: Elsevier; 1991:89-101.
7. Williams RR, Hasstedt SJ, Hunt SC, Wu LL, Hopkins PN, Berry TD, Stults BM, Barlow GK, Kuida H. Genetic traits related to hypertension and electrolyte metabolism. Hypertension. 1991;17(suppl I):I69-I-73.
8. Owens D, Evans J. Population studies on Gilbert's syndrome. J Med Genet. 1975;12:152-156.
9. Bosnia PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GNJ, Jansen PLM, Elferink RPJO, Chowdhury NR. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171-1175.
10. Williams RR, Hunt SC. Recruitment of members of high-risk Utah pedigrees. Controlled Clinical Trials. 1987;8:105S-114S.
11. Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah pedigrees: a screening analysis. Hypertension. 1991;17:969-976.
12. Hunt SC, Hasstedt SJ, Wu LL, Williams RR. A gene-environment interaction between inferred kallikrein genotype and potassium. Hypertension. 1993;22:161-168.
13. Levine JB, Zak B. Automated determination of serum total cholesterol. Clin Chim Acta. 1964;10:381-384.
14. Wahlefeld AW. Triglycerides: determination after enzymatic hydrolysis, In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Vol 4. New York, NY: Academic Press, Inc; 1974:1831-1835.
15. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
16. MacLean CJ, Morton NE, Elston RC, Yee S. Skewness in commingled distributions. Biometrics. 1976;32:695-699.
17. Elston RC, Stewart J. A general model for the genetic analysis of pedigree data. Hum Hered. 1971;21:523-542.
18. Lalouel JM, Rao DC, Morton NE, Elston RC. A unified model for complex segregation analysis. Am J Hum Genet. 1983;35:816-826.
19. Hasstedt SJ. PAP: Pedigree Analysis Package, revision 4. Salt Lake City, UT: Department of Human Genetics, University of Utah; 1993.
20. Lalouel JM. GEMINI: a computer program for optimization of a nonlinear function. Department of Medical Biophysics and Computing, University of Utah; 1979.
21. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043-1046.
22. Stringer MD, Gorog PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. Br Med J. 1989;298:281-284.
23. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.